\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ unknown\\.\ \(0\)\
\-\ canca\\ neg\\.\ \(0\)\
\-\ the\\ patient\\ was\\ intubated\\ and\\ subsequently\\ underwent\\ tracheostomy\\.\\ \\ she\\ is\\ currently\\ still\\ in\\ the\\ intensive\\ care\\ unit\\,\\ day\\ 20\\.\ \(0\)\
\-\ diffuse\\,\\ bilateral\\,\\ hazy\\ airspace\\ opacities\\ predominately\\ in\\ the\\ mid\\ to\\ low\\ lung\\ zones\\.\\ \\ overall\\,\\ these\\ findings\\ are\\ nonspecific\\,\\ but\\ with\\ known\\ history\\ of\\ pulmonary\\ hemorrhage\\ after\\ bronchoscopy\\ or\\ clinical\\ findings\\ of\\ hemoptysis\\ and\\ anemia\\,\\ these\\ findings\\ are\\ consistent\\ with\\ diffuse\\ pulmonary\\ hemorrhage\\.\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ and\\ pulmonary\\-renal\\ syndrome\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ with\\ renal\\ disease\\:\\ \\ wegener\\â\\€\\™s\\ granulomatosis\\,\\ systemic\\ lupus\\ erythematosus\\,\\ goodpasture\\â\\€\\™s\\ syndrome\\,\\ other\\ vasculitides\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ without\\ renal\\ disease\\:\\ \\ anitcoagulation\\,\\ pulmonary\\ infection\\ or\\ neoplasm\\,\\ pulmonary\\ embolism\\,\\ idiopathic\\ pulmonary\\ hemosiderosis\\,\\ trauma\\,\\ bone\\ marrow\\ transplantation\ \(0\)\
\-\ 42\\ year\\ old\\ female\\ with\\ history\\ of\\ scleroderma\\ with\\ new\\ onset\\ seizures\\ and\\ acute\\ renal\\ failure\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.10259795795424918\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.09740604740328888\ \(0\)\
\-\ \\-pulmonary\\:\\ 0\\.09410422294398883\ \(0\)\
\-\ canca\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ pulmonary\\-renal\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ anitcoagulation\\:\\ 0\\.055632679749359946\ \(0\)\
\-\ renal\\:\\ 0\\.05275634690667265\ \(0\)\
\-\ goodpasture\\:\\ 0\\.05088509632086717\ \(0\)\
\-\ hemosiderosis\\:\\ 0\\.04935671583241368\ \(0\)\
\-\ vasculitides\\:\\ 0\\.048107938046153716\ \(0\)\
\-\ tracheostomy\\:\\ 0\\.04183197412920745\ \(0\)\
\-\ 20\\.\\:\\ 0\\.04138992946388162\ \(0\)\
\-\ intensive\\:\\ 0\\.040974692328152616\ \(0\)\
\-\ hazy\\:\\ 0\\.040974692328152616\ \(0\)\
\-\ zones\\:\\ 0\\.03986154897542813\ \(0\)\
\-\ erythematosus\\:\\ 0\\.03986154897542813\ \(0\)\
\-\ transplantation\\:\\ 0\\.038904275397516085\ \(0\)\
\-\ predominately\\:\\ 0\\.03755694461500886\ \(0\)\
\-\ findings\\:\\ 0\\.03737336169431424\ \(0\)\
\-\ wegener\\:\\ 0\\.03731659310945221\ \(0\)\
\-\ scleroderma\\:\\ 0\\.03708439070071467\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.036642346035388844\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.03602856412655537\ \(0\)\
\-\ neg\\:\\ 0\\.035835612914454716\ \(0\)\
\-\ unit\\:\\ 0\\.03546528948109666\ \(0\)\
\-\ diffuse\\:\\ 0\\.035438457813360476\ \(0\)\
\-\ airspace\\:\\ 0\\.03528737519066337\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.034986667666376106\ \(0\)\
\-\ intubated\\:\\ 0\\.0347797863402954\ \(0\)\
\-\ lupus\\:\\ 0\\.0344611560962208\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.033723959766136104\ \(0\)\
\-\ s\\:\\ 0\\.03357215982348749\ \(0\)\
\-\ syndrome\\:\\ 0\\.033478172284036184\ \(0\)\
\-\ opacities\\:\\ 0\\.03053979176217059\ \(0\)\
\-\ these\\:\\ 0\\.030463625917230685\ \(0\)\
\-\ nonspecific\\:\\ 0\\.030114231617602055\ \(0\)\
\-\ 42\\:\\ 0\\.02963617845365999\ \(0\)\
\-\ overall\\:\\ 0\\.029117604332182617\ \(0\)\
\-\ anemia\\:\\ 0\\.029117604332182617\ \(0\)\
\-\ embolism\\:\\ 0\\.02863554408038947\ \(0\)\
\-\ systemic\\:\\ 0\\.028000894556535323\ \(0\)\
\-\ still\\:\\ 0\\.02788072805207704\ \(0\)\
\-\ idiopathic\\:\\ 0\\.026681763685879267\ \(0\)\
\-\ subsequently\\:\\ 0\\.02653339726956982\ \(0\)\
\-\ \\,\\:\\ 0\\.025958499433164542\ \(0\)\
\-\ marrow\\:\\ 0\\.025748442593275273\ \(0\)\
\-\ seizures\\:\\ 0\\.02516338950317697\ \(0\)\
\-\ mid\\:\\ 0\\.024477886362375724\ \(0\)\
\-\ currently\\:\\ 0\\.02319296434939765\ \(0\)\
\-\ failure\\:\\ 0\\.022927796457749085\ \(0\)\
\-\ unknown\\:\\ 0\\.022841640415236345\ \(0\)\
\-\ care\\:\\ 0\\.021110802377183234\ \(0\)\
\-\ new\\:\\ 0\\.020395808060277795\ \(0\)\
\-\ underwent\\:\\ 0\\.020083534489576844\ \(0\)\
\-\ neoplasm\\:\\ 0\\.019932579287068\ \(0\)\
\-\ disease\\:\\ 0\\.01913339097555759\ \(0\)\
\-\ day\\:\\ 0\\.018581916639403628\ \(0\)\
\-\ known\\:\\ 0\\.018520897838793286\ \(0\)\
\-\ onset\\:\\ 0\\.018475487848802395\ \(0\)\
\-\ clinical\\:\\ 0\\.018008971233328796\ \(0\)\
\-\ infection\\:\\ 0\\.01701381215118361\ \(0\)\
\-\ lung\\:\\ 0\\.016953144659169493\ \(0\)\
\-\ she\\:\\ 0\\.016430042064754603\ \(0\)\
\-\ low\\:\\ 0\\.01627512364976986\ \(0\)\
\-\ history\\:\\ 0\\.016167322434343608\ \(0\)\
\-\ trauma\\:\\ 0\\.016006909464095404\ \(0\)\
\-\ are\\:\\ 0\\.01595717633602194\ \(0\)\
\-\ \\:\\:\\ 0\\.01548321665740637\ \(0\)\
\-\ bone\\:\\ 0\\.01454407316068404\ \(0\)\
\-\ acute\\:\\ 0\\.014451228281551336\ \(0\)\
\-\ physical\\:\\ 0\\.01435962513411807\ \(0\)\
\-\ consistent\\:\\ 0\\.014351358005693171\ \(0\)\
\-\ bilateral\\:\\ 0\\.01420423102270167\ \(0\)\
\-\ without\\:\\ 0\\.013780912098343562\ \(0\)\
\-\ or\\:\\ 0\\.013719489711831609\ \(0\)\
\-\ other\\:\\ 0\\.01349067499111266\ \(0\)\
\-\ exam\\:\\ 0\\.012857766711983137\ \(0\)\
\-\ but\\:\\ 0\\.012482899322147517\ \(0\)\
\-\ after\\:\\ 0\\.012109597278145222\ \(0\)\
\-\ female\\:\\ 0\\.012032604598957764\ \(0\)\
\-\ was\\:\\ 0\\.006769024124751279\ \(0\)\
\-\ year\\:\\ 0\\.006548666227896676\ \(0\)\
\-\ old\\:\\ 0\\.00599270271823462\ \(0\)\
\-\ patient\\:\\ 0\\.00586706801997526\ \(0\)\
\-\ in\\:\\ 0\\.005772564796441848\ \(0\)\
\-\ and\\:\\ 0\\.004931753581704615\ \(0\)\
\-\ with\\:\\ 0\\.004006992331845539\ \(0\)\
\-\ is\\:\\ 0\\.003851306701265244\ \(0\)\
\-\ to\\:\\ 0\\.0029251240304314125\ \(0\)\
\-\ the\\:\\ 0\\.0028407387267868314\ \(0\)\
\-\ of\\:\\ 0\\.0023939137150271596\ \(0\)\
\-\ \\.\\:\\ 0\\.001458885045096422\ \(0\)\
